Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX   3:59:51 PM EDT
2.04
-0.12 (-5.56%)
Products

Amneal Announces Submission Of New Drug Application To The U.S. FDA For IPX203 For The Treatment Of Parkinson’s Disease

Published: 08/31/2022 20:43 GMT
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A (AMRX) - Amneal Announces Submission of New Drug Application to the U.S. FDA for Ipx203 for the Treatment of Parkinson’s Disease.